Obesity-and aging-induced excess of central transforming growth factor-β 2 potentiates diabetic development via an RNA stress response

Nature Medicine

Volumn 20, Issue 9, 2014, Pages 1001-1008

  Yan, Jingqi ^a   Zhang, Hai ^a   Yin, Ye ^a   Li, Juxue ^a   Tang, Yizhe ^a   Purkayastha, Sudarshana ^a   Li, Lianxi ^a   Cai, Dongsheng ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROOPIOMELANOCORTIN; RNA; TRANSFORMING GROWTH FACTOR BETA;

AGING; ARTICLE; ASTROCYTE; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMAN; HYPOTHALAMUS; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

AGING; ASTROCYTES; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMANS; HYPOTHALAMUS; NF-KAPPA B; OBESITY; PRO-OPIOMELANOCORTIN; RNA; STRESS, PHYSIOLOGICAL; TRANSFORMING GROWTH FACTOR BETA;

EID: 84908344159     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3616     Document Type: Article

References (66)

1. Samuel, V.T., Shulman, G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852-871 (2012).
2. Gregor, M.F., Hotamisligil, G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445 (2011).
3. Muoio, D.M., Newgard, C.B. Obesity-related derangements in metabolic regulation. Annu. Rev. Biochem. 75, 367-401 (2006).
4. Glass, C.K., Olefsky, J.M. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 15, 635-645 (2012).
5. Mighiu, P.I. et al. Hypothalamic glucagon signaling inhibits hepatic glucose production. Nat. Med. 19, 766-772 (2013).
6. Berglund, E.D. et al. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J. Clin. Invest. 122, 1000-1009 (2012).
7. Obici, S., Zhang, B.B., Karkanias, G., Rossetti, L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8, 1376-1382 (2002).
8. Lam, T.K. et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11, 320-327 (2005).
9. Joly-Amado, A. et al. Hypothalamic AgRP-neurons control peripheral substrate utilization and nutrient partitioning. EMBO J. 31, 4276-4288 (2012).
10. Wisse, B.E., Kim, F., Schwartz, M.W. Physiology. An integrative view of obesity. Science 318, 928-929 (2007).
11. Cone, R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 8, 571-578 (2005).
12. Cai, D. Neuroinflammation and neurodegeneration in overnutrition-induced diseases 2250. Trends Endocrinol. Metab. 24, 40-47 (2013).
13. Cai, D., Liu, T. Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann. NY Acad. Sci. 1243, E1-E39 (2011).
14. Zhang, X. et al. Hypothalamic IKK/NF-B and ER stress link overnutrition to energy imbalance and obesity. Cell 135, 61-73 (2008).
15. De Souza, C.T. et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192-4199 (2005).
16. Kleinridders, A. et al. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 10, 249-259 (2009).
17. Horvath, T.L. et al. Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc. Natl. Acad. Sci. USA 107, 14875-14880 (2010).
18. Meng, Q., Cai, D. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IB kinase (IKK)/NF-B pathway. J. Biol. Chem. 286, 32324-32332 (2011).
19. Purkayastha, S. et al. Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc. Natl. Acad. Sci. USA 108, 2939-2944 (2011).
20. Purkayastha, S., Zhang, G., Cai, D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-and NF-B. Nat. Med. 17, 883-887 (2011).
21. Milanski, M. et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 61, 1455-1462 (2012).
22. Thaler, J.P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153-162 (2012).
23. Zhang, G. et al. Hypothalamic programming of systemic ageing involving IKK-, NF-B and GnRH. Nature 497, 211-216 (2013).
24. Purkayastha, S., Cai, D. Neuroinflammatory basis of metabolic syndrome. Mol. Metab. 2, 356-363 (2013).
25. Tang, Y., Cai, D. Hypothalamic inflammation and GnRH in aging development. Cell Cycle 12, 2711-2712 (2013).
26. Li, J., Tang, Y., Cai, D. IKK/NF-B disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes. Nat. Cell Biol. 14, 999-1012 (2012).
27. Li, J. et al. Control of obesity and glucose intolerance via building neural stem cells in the hypothalamus. Mol. Metab. 3, 313-324 (2014).
28. Wan, Y.Y., Flavell, R.A. 'Yin-Yang' functions of transforming growth factor-and T regulatory cells in immune regulation. Immunol. Rev. 220, 199-213 (2007).
29. Li, M.O. et al. Transforming growth factor-regulation of immune responses. Annu. Rev. Immunol. 24, 99-146 (2006).
30. Hall, B.E. et al. Conditional overexpression of TGF-1 disrupts mouse salivary gland development and function. Lab. Invest. 90, 543-555 (2010).
31. Bouret, S. et al. Evidence that TGF may directly modulate POMC mRNA expression in the female rat arcuate nucleus. Endocrinology 142, 4055-4065 (2001).
32. Falk, S. et al. Brain area-specific effect of TGF-signaling on Wnt-dependent neural stem cell expansion. Cell Stem Cell 2, 472-483 (2008).
33. Beynon, A.L., Thome, J., Coogan, A.N. Age and time of day influences on the expression of transforming growth factor-and phosphorylated SMAD3 in the mouse suprachiasmatic and paraventricular nuclei. Neuroimmunomodulation 16, 392-399 (2009).
34. Padilla, S.L., Carmody, J.S., Zeltser, L.M. Pomc-expressing progenitors give rise to antagonistic neuronal populations in hypothalamic feeding circuits. Nat. Med. 16, 403-405 (2010).
35. Scherf, W., Burdach, S., Hansen, G. Reduced expression of transforming growth factor 1 exacerbates pathology in an experimental asthma model. Eur. J. Immunol. 35, 198-206 (2005).
36. Thomas, M.G., Loschi, M., Desbats, M.A., Boccaccio, G.L. RNA granules: the good, the bad and the ugly. Cell. Signal. 23, 324-334 (2011).
37. Buchan, J.R., Parker, R. Eukaryotic stress granules: the ins and outs of translation. Mol. Cell 36, 932-941 (2009).
38. Anderson, P., Kedersha, N. Stress granules: the Tao of RNA triage. Trends Biochem. Sci. 33, 141-150 (2008).
39. Dai, Y., Kamal, M.A. Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies. CNS Neurol. Disord. Drug Targets 13, 271-282 (2014).
40. McCrimmon, R.J., Ryan, C.M., Frier, B.M. Diabetes and cognitive dysfunction. Lancet 379, 2291-2299 (2012).
41. de la Monte, S.M., Wands, J.R. Alzheimer's disease is type 3 diabetes-evidence reviewed. J. Diabetes Sci. Technol. 2, 1101-1113 (2008).
42. Luo, J. et al. Glia-dependent TGF-signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. J. Clin. Invest. 117, 3306-3315 (2007).
43. Izecka, J., Stelmasiak, Z., Dobosz, B. Transforming growth factor-1 (TGF-1) in patients with amyotrophic lateral sclerosis. Cytokine 20, 239-243 (2002).
44. Tarkowski, E. et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-in Alzheimer's disease and vascular dementia. Neurobiol. Aging 23, 237-243 (2002).
45. Wyss-Coray, T., Borrow, P., Brooker, M.J., Mucke, L. Astroglial overproduction of TGF-1 enhances inflammatory central nervous system disease in transgenic mice. J. Neuroimmunol. 77, 45-50 (1997).
46. Grammas, P., Ovase, R. Cerebrovascular transforming growth factor-contributes to inflammation in the Alzheimer's disease brain. Am. J. Pathol. 160, 1583-1587 (2002).
47. Böttinger, E.P., Letterio, J.J., Roberts, A.B. Biology of TGF-in knockout and transgenic mouse models. Kidney Int. 51, 1355-1360 (1997).
48. Dünker, N., Krieglstein, K. Tgf2/Tgf3/double knockout mice display severe midline fusion defects and early embryonic lethality. Anat. Embryol. (Berl.) 206, 73-83 (2002).
49. Heupel, K. et al. Loss of transforming growth factor-2 leads to impairment of central synapse function. Neural Dev. 3, 25 (2008).
50. Vogel, T., Ahrens, S., Buttner, N., Krieglstein, K. Transforming growth factor promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component. Cereb. Cortex 20, 661-671 (2010).
51. Ziyadeh, F.N. et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-antibody in db/db diabetic mice. Proc. Natl. Acad. Sci. USA 97, 8015-8020 (2000).
52. Yadav, H. et al. Protection from obesity and diabetes by blockade of TGF-/Smad3 signaling. Cell Metab. 14, 67-79 (2011).
53. Hayden, M.S., Ghosh, S. Shared principles in NF-B signaling. Cell 132, 344-362 (2008).
54. Veldhoen, M. et al. TGF in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
55. Mangan, P.R. et al. Transforming growth factor-induces development of the TH17 lineage. Nature 441, 231-234 (2006).
56. Calegari, V.C. et al. Inflammation of the hypothalamus leads to defective pancreatic islet function. J. Biol. Chem. 286, 12870-12880 (2011).
57. Milanski, M. et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 29, 359-370 (2009).
58. Ropelle, E.R. et al. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKK and ER stress inhibition. PLoS Biol. 8, e1000465 (2010).
59. Gao, Y. et al. Hormones and diet, but not body weight, control hypothalamic microglial activity. Glia 62, 17-25 (2014).
60. Ito, Y. et al. GABA type B receptor signaling in proopiomelanocortin neurons protects against obesity, insulin resistance, and hypothalamic inflammation in male mice on a high-fat diet. J. Neurosci. 33, 17166-17173 (2013).
61. Garcia, A.D. et al. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 7, 1233-1241 (2004).
62. Azhar, M. et al. Generation of mice with a conditional allele for transforming growth factor 1 gene. Genesis 47, 423-431 (2009).
63. Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
64. Yoshinaga, K. et al. Perturbation of transforming growth factor (TGF)-1 association with latent TGF-binding protein yields inflammation and tumors. Proc. Natl. Acad. Sci. USA 105, 18758-18763 (2008).
65. Zhang, H. et al. Hypoxia-inducible factor directs POMC gene to mediate hypothalamic glucose sensing and energy balance regulation. PLoS Biol. 9, e1001112 (2011).
66. Zhang, G. et al. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron 69, 523-535 (2011).